Global "Urinary Incontinence Market" 2018 Share | Trend | Segmentation | Trends | Business Growth | Major Players: NeoTract, Promedon, Cook Medical Inc and Coloplast Corp Forecast to 2022 | MarketResearchFuture.com

The, Urinary Incontinence Market inquire about report is developing with the quick pace; chiefly due the prospering Healthcare Sector. As per a current report distributed by the Market Research Future, The Urinary Incontinence Industry Research report is blasting and anticipated that would pick up unmistakable quality over the conjecture time frame. The Market is anticipated to exhibit a colossal development by 2022, outperforming its past development records as far as esteem and volume.

You can get easy access to sample report here, please click: https://www.marketresearchfuture.com/sample_request/1097 .

The urinary incontinence market is anticipated to grow at a CAGR rate of ~ 3% to 4% during the forecast period of 2016 to 2022.

Global Urinary Incontinence Market – Regional Analysis:
Globally Americas is the largest market for Urinary Incontinence. Where in countries like US and Canada play an important role in the growth of the market. Europe is expected to be the second-largest market which is expected to grow at a CAGR of ~4% by the end of the forecasted period 2016-2022. Furthermore Asia pacific market is expected to be the fastest growing market for Urinary Incontinence.

The market of urinary incontinence drugs is much higher in Asia Pacific region, owing to obesity population, high consumption of alcohol, consumption of spicy foods, and large doses of vitamin C. These are the factors which fuels the urinary incontinence drugs market in this region. Most of the countries of this region have common lifestyle and economic conditions and are focusing more to enhance the treatment option. Thus, more research and development programs are initiated for the development of new drugs. Government of developing countries within this region are willing to adopt advanced treatment option available in developed countries, which fuel the market of urinary incontinence. These advance drugs will overcome the saturation that occurs during last few years. Countries like India and china are more focused market for global market players owing to huge patient population and growing purchasing power as compare to other countries in this region. Japan is well developed country and have advanced healthcare system and technology, whereas developing countries are still focusing on new drugs and technology for the treatment of urinary incontinence patients, the unmet market needs has to be fulfilled by introducing advanced and better treatment options.

Key Players for Urinary Incontinence Market:
Some of the key players in this market are: NeoTract, Inc, Promedon, Cook Medical Inc., C.R. Bard Inc., Coloplast Corp, Boston Scientific Corporation, Ethicon US, LLC and others

Global Urinary Incontinence Market – Market Scenario:
Urinary Incontinence (UI) is a medical condition characterized by unconscious urination, urine leakage. The urinary incontinence market is anticipated to grow at a CAGR rate of ~ 3% to 4% during the forecast period of 2016 to 2022.

Urinary incontinence is the knee-jerk leakage of urine, it is also known as involuntary urination. It is an awkward situation where leakage of urine create embarrassing situation in public. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, women were more likely to suffer with the urinary incontinence in comparison to men. Statistics shows that women accounts 1.2 times more episode of urinary incontinence than men. Sudden extra presser on bladder and muscles involved in urinary control leads the urinary incontinence episode.

The global urinary incontinence market is showing average growth; mainly due to increase in obesity population, urinary tract infection, and high consumption of alcohol. There are incidences reported where stress causes the urinary incontinence. Urinary incontinency is a result of a number of diseases like polyuria, prostate cancer, enlarged prostate, Parkinson’s disease, multiple sclerosis, spinal cord injury, and many more. According to a report published by the Centers for Disease Control and Prevention (CDC), in 2014, around 50.9% of persons aged 65 year reported a urinary leakage or accidental bowel leakage. According to the Urology Care Foundation, in 2015, quarter to a third of men and women in the United States were suffering from involuntary urination. Millions of the Americans are facing the problems of involuntary urination and about 33 million have overactive bladder representing symptoms of urgency, frequency and with or without urge incontinence.

Companies are showing much interest toward the market of involuntary urination, as they feels there are huge opportunity and gap between the market demand and supply of effective treatments. Thus, companies are showing more interest in merger and acquisition activities for introducing best cure that meet the requirement of the market. The development has been made by Boston Scientific Corporation in 2015, where they announced the agreement with Endo International plc. to acquire American Medical Systems’ urology portfolio, for cementing the global leadership position in the urology devices and provide strong treatment options in the market. This agreement includes the buying rights for men’s health and prostate health businesses, for $1.6 billion in up-front cash and a potential additional $50 million milestone based on 2016 sales. This acquisition will leads to innovation in better way and help them to compete there competitor with more effective manner. Boston Scientific Corporation try to feel the gap along with market players such as Ethicon Inc., Coloplast Corp, C. R. Bard, Inc., Promedon, NeoTract, Inc., ConvaTec Group plc, Procter & Gamble Co., and Marlen Manufacturing.

Increasing in the prevalence of urinary incontinence around the globe is creating the huge scope for the market players to make profit. There are three drugs that accounts 80% of prescribe volume, these includes solifenacin, oxybutynin, and tolterodine. Solifenacin capture 37% of prescribe volume followed by 28% by oxybutynin, and tolterodine capture 18% of the market.

Ethicon Inc. (U.S.), Boston Scientific Corporation (U.S.), Coloplast Corp (Europe), C. R. Bard, Inc. (U.S.), Promedon (U.S.), NeoTract, Inc. (U.S.), ConvaTec Group plc. (Europe), Procter & Gamble Co. (U.S.), and Marlen Manufacturing (U.S.) are some of the leading players at the cutting edge of the competition in the market of urinary incontinence market, globally.

Any query or specific requirement? Ask to our industry expert, please click: https://www.marketresearchfuture.com/enquiry/1097 .

Market Dynamics:
Drivers
Growing incidence and prevalence of urinary incontinence due to rise in risk factors such as spinal cord injury, Polyuria, prostate cancer, diabetes, enlarged prostate, multiple sclerosis, Parkinson’s disease etc. are the prime drivers of the market.

due to conditions such as certain typ`es of UI such as Stress incontinence (leakage of urine due to pressure on bladder by sneezing, coughing, etc.), Urge incontinence (Strong urge of urination which leads to unconscious loss of urine), Overflow incontinence (constant dripping of urine due to the bladder which doesn’t get empty totally) and Mixed incontinence (patient suffering from more than one type of urinary incontinence). Depending on these types of incontinence, physicians prescribe specific treatments.

Restraints:

Key Finding:
The global market for Urinary Incontinence is expected to reach $27,775.9 million by 2022.
Stress Incontinence segment holds the largest share in the global market.
North America holds the largest market share in terms of geographies for Urinary Incontinence market
Globally, Europe and Asia-Pacific are expected to be fastest growing regions which are expected to grow in a range of 4% to 5% respectively.

Segments:
Urinary Incontinence market has been segmented on the basis of types which comprises Urge incontinence, Stress Incontinence, Overflow incontinence, Functional incontinence and others. On the basis of devices the market is segmented into Electrical Stimulation Devices, Foley Catheters, Antimicrobial Foley Catheters, Urethral Bulking Agents and others.

What makes our report unique?
1) An extensive research study on the Global Urinary Incontinence market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Urinary Incontinence market.

2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

…CONTINUED FOR TOC

Feel free to get in touch for discounts and customized details: https://www.marketresearchfuture.com/check-discount/1097 .

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.